[Antinuclear autoantibodies in systemic diseases].
D001172:Arthritis, Rheumatoid / Q000276:immunology; D001323:Autoantibodies / Q000032:analysis* / Q000276:immunology; D001327:Autoimmune Diseases / Q000276:immunology; D001666:Binding Sites, Antibody; D002467:Cell Nucleus / Q000276:immunology*; D003165:Complement System Proteins / Q000276:immunology; D003882:Dermatomyositis / Q000276:immunology; D005453:Fluorescence; D005455:Fluorescent Antibody Technique; D006801:Humans; D007074:Immunoglobulin G / Q000276:immunology; D066298:In Vitro Techniques; D008179:Lupus Erythematosus, Discoid / Q000276:immunology; D008180:Lupus Erythematosus, Systemic / Q000276:immunology*; D012594:Scleroderma, Localized / Q000276:immunology; D012595:Scleroderma, Systemic / Q000276:immunology*
D001323:Autoantibodies; D007074:Immunoglobulin G; D003165:Complement System Proteins
Antinuklearnye autoantitela u bol'nykh sistemnymi zabolevaniiami.